XOMA (US) LLC

ACTIVE

2910 7TH St Ste 100, Berkeley, California, United StatesSubsidiary

Clinical Trials

16 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

29.3%

Phase 1

24.4%

Phase 3

17.1%

Not Applicable

2.4%

Trial Status Distribution

Active, not recruiting

39.0%

Completed

39.0%

Suspended

2.4%

Terminated

19.5%

Clinical Trials

Trials sponsored by this organization (41)

A non-blinded study of XOMA 358, with a possibility to increase the dose, in patients with abnormal levels of insulin due to a genetic dysfunctio

Phase 1

Active, not recruiting

Apr 2016

An Open-Label Study of XOMA 358 in Patients With Hypoglycemia After Gastric Bypass Surgery

Phase 2

Completed

interventional

Apr 201620 participants

A study of XOMA 213 in the reduction of breast milk production in women after child birth.

Phase 1

Active, not recruiting

Mar 2016

A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism

Phase 2

Completed

interventional

Oct 201510 participants

A single-dose study of a new biologic drug for people with abnormal levels of insulin due to a genetic dysfunctio

Phase 1

Active, not recruiting

Aug 201510 participants

An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum

Phase 3

Terminated

interventional

Dec 20149 participants

Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis

Phase 3

Terminated

interventional

Nov 20144 participants

An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum

Phase 3

Terminated

interventional

Nov 201416 participants

Page 1 of 6

Approvals

Approvals by Agency

FDA

Food and Drug Administration

Approvals

Recent Approvals

News

No news articles found

Back to Organizations